|
US7345019B1
(en)
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
US7410941B1
(en)
|
1999-04-13 |
2008-08-12 |
The Kenneth S. Warren Institute, Inc. |
Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US6855544B1
(en)
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US7604960B2
(en)
|
1999-04-15 |
2009-10-20 |
Crucell Holland B.V. |
Transient protein expression methods
|
|
US8236561B2
(en)
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7527961B2
(en)
|
1999-11-26 |
2009-05-05 |
Crucell Holland B.V. |
Production of vaccines
|
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
NZ533124A
(en)
|
2001-12-07 |
2005-11-25 |
Crucell Holland B |
Production of viruses, viral isolates and vaccines
|
|
CN100383238C
(zh)
|
2003-05-09 |
2008-04-23 |
克鲁塞尔荷兰公司 |
E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法
|
|
EP1844068A4
(en)
*
|
2005-01-25 |
2009-09-30 |
Apollo Life Sciences Ltd |
MOLECULES AND THEIR CHIMERIC MOLECULES
|
|
ME00380B
(me)
|
2005-11-23 |
2011-10-10 |
Acceleron Pharma Inc |
Amtagonisti aktivin-actriia i primjene za stimulaciju rasta kosti
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
CA2621705A1
(en)
*
|
2005-11-24 |
2007-05-31 |
Laboratoires Serono S.A. |
Erythropoietin polypeptides and uses thereof
|
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
US9526759B2
(en)
|
2007-02-01 |
2016-12-27 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for treating or preventing breast cancer
|
|
TW201940502A
(zh)
|
2007-02-02 |
2019-10-16 |
美商艾瑟勒朗法瑪公司 |
衍生自ＡｃｔＲＩＩＢ的變體與其用途
|
|
KR101672156B1
(ko)
|
2007-02-09 |
2016-11-02 |
악셀레론 파마 인코포레이티드 |
액티빈-ＡｃｔＲⅡＡ 길항제 및 암 환자에서 골 생장을 촉진시키기 위한 이의 용도
|
|
CN107412734A
(zh)
|
2007-09-18 |
2017-12-01 |
阿塞勒隆制药公司 |
活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
|
|
LT3750552T
(lt)
|
2008-08-14 |
2023-06-26 |
Acceleron Pharma Inc. |
Gdf gaudyklės
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
MX385318B
(es)
|
2009-06-08 |
2025-03-18 |
Acceleron Pharma Inc |
Metodos para aumentar adipocitos termogenicos.
|
|
JP2012529294A
(ja)
|
2009-06-12 |
2012-11-22 |
アクセルロン ファーマ， インコーポレイテッド |
切断型ＡｃｔＲＩＩＢ−Ｆｃ融合タンパク質
|
|
EP2501400B1
(en)
|
2009-11-17 |
2017-11-01 |
Acceleron Pharma, Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
WO2012064771A1
(en)
|
2010-11-08 |
2012-05-18 |
Acceleron Pharma, Inc. |
Actriia binding agents and uses thereof
|
|
LT3401402T
(lt)
|
2012-06-08 |
2020-12-28 |
Alkermes Pharma Ireland Limited |
Ligandai, modifikuoti cirkuliarinės permutacijos pagalba, kaip agonistai ir antagonistai
|
|
RU2018145985A
(ru)
|
2012-11-02 |
2019-02-18 |
Селджин Корпорейшн |
Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
|
|
TN2016000553A1
(en)
|
2014-06-13 |
2018-04-04 |
Acceleron Pharma Inc |
Methods and compositions for treating ulcers
|
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
|
DK3227675T3
(da)
|
2014-12-03 |
2023-05-30 |
Celgene Corp |
Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom
|
|
CN110144010B9
(zh)
|
2018-02-14 |
2021-01-05 |
上海洛启生物医药技术有限公司 |
阻断型pd-l1驼源单域抗体及其用途
|